Back to Trades
Erdogan-Trinkaus Ipek
Chief Commercial OfficerCIK 0002047026
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Erdogan-Trinkaus Ipek, Chief Commercial Officer, accounts for 3 disclosed filings worth $630.4K, all concentrated in Eton Pharmaceuticals, Inc. (ETON), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 4 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Award | $0 |
| Jan 14 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Award | $628.9K |
| Dec 12 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Tax withheld | $1.4K |
3 filings